"I recommend CNS Neurological Disorders & Drug Targets to neuroscientists and practicing neurologists. The papers published on this platform are always of sufficient merit and quality. It maintains the highest standards of peer review, preserving the integrity of science"
Abdelrahman Ibrahim Abushouk (Faculty of Medicine, Ain Shams University, Cairo, Egypt)
"On behalf of all authors, I wanted to take a few moments to reflect favorably on our experience in having our manuscript "Utilizing Delta Opioid Receptors And Peptides For Cytoprotection: Implications In Stroke And Other Neurological Disorders" published in CNS & Neurological Disorders - Drug Targets. We extend our appreciation for the professionalism, efficient communication, and expeditious pace of publication which we have experienced with your journal, and we look forward to future opportunities to contribute to your respected, high-quality journals."
Cesar V. Borlongan (Morsani College of Medicine, University of South Florida, United States)
"I am extremely grateful for working with Bentham Science. In my opinion, it is one of the best publishers."
Gjumrakch Aliev, MD & PhD (President "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX, USA)
"For me it is a honor be part of CNSNDDT. As an editorial board member, my mission is work hard to contribute to CNSNDDT, either as author or as reviewer, allowing the progress of our jornal."
Dr. Sergio Machado (The Panic and Respiration Laboratory, Institute of Psychiatry (IPUB) – Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
"I have nothing but positive comments for Bentham Science Publishers, as my experience has always been pleasant. I have always received prompt service from Bentham Science."
Dr. Celina S. Liu (Department of Human Biology, University of Toronto, Toronto, ON, Canada)
"I have had a great experience working with Bentham Science Publishers! I published my papers not only in CNS, but in other BSP journals as well. Their publishing process is fast and efficient."
Dr. Prof.. Sergio Machado (Institute of Psychiatry, Federal, Brazil)
"I found the handling and reviewing of our manuscripts problem-free; feedback from the referees was both rapid and constructive. Galley proofs were received only a short time after acceptance. I have already received a number of enquiries from the scientific community for a copy. I would definitely recommend CNS & Neurological Disorders - Drug Targets to authors for their future publications."
Dr. Stephen Skaper (Editor-in-Chief CNS & Neurological Disorders-Drug Targets, )
Cesar V. Borlongan Department of Neurosurgery and Brain Repair University of South Florida Morsani College of Medicine Tampa, FL USA
CESAR V. BORLONGAN, Distinguished Professor, Vice-Chairman for Research, and Director of USF Morsani College of Medicine’s Center of Excellence for Aging and Brain Repair. His highly innovative translational “bench to clinic” research has led to FDA-approved clinical trials of cell transplantation in CNS disorders. He is an author of >370 peer-reviewed publications. He is funded by and a regular reviewer for NIH, DOD, and VA. He was the President-Elect of American Society for Neural Therapy and Repair, and International Placenta Stem Cell Society, and is an elected Fellow of AAAS and AIMBE. He was featured in The Lancet in 2008.